Jounce stock price
Nettet12. apr. 2024 · The average twelve-month price prediction for Jounce Therapeutics is $6.00 with a high price target of $11.00 and a low price target of $3.00. Do Wall Street analysts like Jounce Therapeutics more than its competitors? Analysts like Jounce Therapeutics less than other Medical companies. NettetJNCE Stock 12 Months Forecast. $1.85. (0.00% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Jounce Therapeutics in the last 3 months. The …
Jounce stock price
Did you know?
NettetFollowing a buyout offer from Concentra Biosciences, Jounce’s stock price surged over 20% in Monday’s trading session. The acquisition deal proposed that Concentra would acquire Jounce for $1.85 per share, along with a non-tradeable contingent value right. Nettet18. apr. 2024 · According to our current JNCE stock forecast, the value of Jounce Therapeutics, Inc. shares will rise by 5.41%and reach $ 3.68 per share by September 14, 2024. According to our technical indicators, the current sentiment is Bearishwhile the Fear & Greed Index is showing 39 (Fear).
NettetCurrent and historical p/e ratio for Jounce Therapeutics (JNCE) from 2015 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. NettetFind real-time JNCE - Jounce Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. ... Price/Sales: 0.70: Price/Book: 0.52: Competitors …
Nettet14. apr. 2024 · Five investment analysts have rated the stock with a hold rating and one has issued a buy rating to the company's stock. Based on data from MarketBeat, Jounce Therapeutics presently has an average rating of "Hold" and a consensus target price of $6.00. Jounce Therapeutics Price Performance. Shares of NASDAQ:JNCE opened at … Nettet12. apr. 2024 · According to analysts' consensus price target of $6.00, Jounce Therapeutics has a forecasted upside of 298.7% from its current price of $1.51. …
NettetJounce Therapeutics Inc (JNCE) Stock Price Today, News, Quotes, FAQs and Fundamentals More Advertisement 3rd Party Ad. Not an offer or recommendation by …
NettetJounce Therapeutics Enters Into Agreement to Be Acquired by Concentra Biosciences for $1.85 in Cash per Share Plus Contingent Value Rights March 27, 2024TipRanks. … st cuthmansNettetJounce Therapeutics Inc Follow Share $1.61 After Hours: $1.65 (2.48%) +0.040 Closed: Mar 17, 7:54:00 PM GMT-4 · USD · NASDAQ · Disclaimer search Compare to Loyalty … st cuthburgaNettetUse our historic performance chart to see real-time Jounce Therapeutics Inc stock price and the Jounce Therapeutics Inc news feed to help further your research before investing in fractional shares with any dollar amount you choose. 2. Choose a Stash plan and set up your investment account in just a few minutes. st cuthberts wroseNettetJounce Therapeutics Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Your browser of choice has not … st cuthberts wrose bradfordNettet18. mar. 2024 · Jounce Therapeutics stock was originally listed at a price of $17.25 in Jan 27, 2024. If you had invested in Jounce Therapeutics stock at $17.25, your return over … st cuthburts twitter leicesterNettetJounce Therapeutics, Inc. is a clinical-stage immunotherapy company. It engaged in developing therapies which enable the immune system to attack tumors. The Company's lead product candidate, JTX-2011, is a clinical-stage monoclonal antibody that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of certain T ... st cuths college durhamNettet31. mar. 2024 · Complete Jounce Therapeutics Inc. stock information by Barron's. View real-time JNCE stock price and news, along with industry-best analysis. st cwyfan\u0027s church aber